LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
1-Year Return
16.78%
This Quarter Return
-2.14%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$109M
AUM Growth
-$25.5M
(-19%)
Cap. Flow
-$17.5M
Cap. Flow
% of AUM
-16.05%
Top 10 Holdings %
Top 10 Hldgs %
91.03%
Holding
36
New
5
Increased
4
Reduced
4
Closed
5
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$824K |
| 2 |
Travere Therapeutics
TVTX
|
$697K |
| 3 |
Humacyte
HUMA
|
$689K |
| 4 |
Replimune Group
REPL
|
$599K |
| 5 |
Insmed
INSM
|
$505K |
Top Sells
| 1 |
Chord Energy
CHRD
|
$15.7M |
| 2 |
Ardelyx
ARDX
|
$1.43M |
| 3 |
TSVT
2seventy bio
TSVT
|
$1.13M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$903K |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$761K |
Sector Composition
| 1 | Technology | 57.83% |
| 2 | Healthcare | 20.69% |
| 3 | Consumer Discretionary | 2.91% |
| 4 | Energy | 2.16% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$318B
| $7.76K | ﹤0.01% |
+46
| New | +$7.76K |
|
|
27
Chord Energy
CHRD
$6.15B
| – | – |
-102,403
| Closed | -$15.7M |
|
28
iShares Russell 2000 ETF
IWM
$67.4B
| – | – |
0
| – | – |
|
29
Mersana Therapeutics
MRSN
$35.5M
| – | – |
0
| – | – |
|
30
Origin Materials
ORGN
$78.7M
| – | – |
-100,000
| Closed | -$426K |
|
31
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
|
TSVT
32
DELISTED
2seventy bio
TSVT
| – | – |
-111,667
| Closed | -$1.13M |
|
|
BFIIW
33
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
| – | – |
0
| – | – |
|
|
PDCE
34
DELISTED
PDC Energy, Inc.
PDCE
| – | – |
-100
| Closed | -$7.11K |
|
|
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-7,400
| Closed | -$761K |
|